PlainRecalls
FDA Drug Moderate Class II Completed

Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.03 mg, 28 Tablets Blister, 1 Unit (NDC 60505-4183-1) packaged as 84 Tablets Blister, 3x1 Unit per carton (NDC 60505-4183-3), Rx Only, Manufactured for: Apotex Corp., Weston, FL 33326; Manufactured by: Oman Pharmaceutical Products Co. L.L.C., P.O. Box 1885, Postal Code 111, Seeb.

Reported: March 13, 2019 Initiated: March 1, 2019 #D-0992-2019

Product Description

Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.03 mg, 28 Tablets Blister, 1 Unit (NDC 60505-4183-1) packaged as 84 Tablets Blister, 3x1 Unit per carton (NDC 60505-4183-3), Rx Only, Manufactured for: Apotex Corp., Weston, FL 33326; Manufactured by: Oman Pharmaceutical Products Co. L.L.C., P.O. Box 1885, Postal Code 111, Seeb.

Reason for Recall

Contraceptive Tablets Out of Sequence: Missing or incorrect tablet placement.

Details

Recalling Firm
Apotex Inc.
Units Affected
82,705 cartons
Distribution
Nationwide in the USA.
Location
North York, N/A

Frequently Asked Questions

What product was recalled?
Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.03 mg, 28 Tablets Blister, 1 Unit (NDC 60505-4183-1) packaged as 84 Tablets Blister, 3x1 Unit per carton (NDC 60505-4183-3), Rx Only, Manufactured for: Apotex Corp., Weston, FL 33326; Manufactured by: Oman Pharmaceutical Products Co. L.L.C., P.O. Box 1885, Postal Code 111, Seeb.. Recalled by Apotex Inc.. Units affected: 82,705 cartons.
Why was this product recalled?
Contraceptive Tablets Out of Sequence: Missing or incorrect tablet placement.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 13, 2019. Severity: Moderate. Recall number: D-0992-2019.